Lixia Yu

4.5k total citations
145 papers, 3.3k citations indexed

About

Lixia Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lixia Yu has authored 145 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 43 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Lixia Yu's work include Nanoplatforms for cancer theranostics (18 papers), Nanoparticle-Based Drug Delivery (17 papers) and Immunotherapy and Immune Responses (16 papers). Lixia Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (18 papers), Nanoparticle-Based Drug Delivery (17 papers) and Immunotherapy and Immune Responses (16 papers). Lixia Yu collaborates with scholars based in China, Spain and United States. Lixia Yu's co-authors include Baorui Liu, Xiaoping Qian, Rutian Li, Jia Wei, Xiaoping Qian, Mi Yang, Hanqing Qian, Qin Liu, Xiqun Jiang and Zhengyun Zou and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lixia Yu

144 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixia Yu China 33 1.7k 859 752 688 613 145 3.3k
Xiaoping Qian China 31 1.4k 0.8× 710 0.8× 797 1.1× 559 0.8× 395 0.6× 124 2.9k
Ling Ding China 36 2.2k 1.2× 662 0.8× 507 0.7× 589 0.9× 800 1.3× 135 4.2k
Aiping Tong China 38 2.3k 1.3× 1.5k 1.8× 611 0.8× 785 1.1× 440 0.7× 174 5.1k
Lingli Chen China 32 1.5k 0.9× 772 0.9× 765 1.0× 1.1k 1.7× 420 0.7× 103 4.0k
Anupama Munshi United States 42 3.0k 1.7× 1.3k 1.5× 636 0.8× 617 0.9× 960 1.6× 85 4.8k
Khaled Seidi Iran 26 1.2k 0.7× 734 0.9× 447 0.6× 696 1.0× 524 0.9× 37 2.8k
Xiaodong Xie China 32 1.7k 1.0× 625 0.7× 375 0.5× 506 0.7× 614 1.0× 141 3.2k
Jia Wei China 37 1.5k 0.8× 1.6k 1.8× 328 0.4× 716 1.0× 541 0.9× 177 3.9k
Mohammad Hojjat‐Farsangi Sweden 36 1.8k 1.0× 1.1k 1.3× 386 0.5× 432 0.6× 464 0.8× 139 4.0k

Countries citing papers authored by Lixia Yu

Since Specialization
Citations

This map shows the geographic impact of Lixia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Yu more than expected).

Fields of papers citing papers by Lixia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Yu. The network helps show where Lixia Yu may publish in the future.

Co-authorship network of co-authors of Lixia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Yu. A scholar is included among the top collaborators of Lixia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Yu. Lixia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ke, Yaohua, Kai Xin, Yaping Tao, et al.. (2024). A Thermosensitive Bi‐Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti‐Tumor Efficacy of Frameshift Neoantigens. Advanced Science. 11(14). e2306889–e2306889. 10 indexed citations
2.
Ke, Yaohua, Ying Liang, Shuxian Zhang, et al.. (2024). An Immune‐Enhancing Injectable Hydrogel Loaded with Esketamine and DDP Promotes Painless Immunochemotherapy to Inhibit Breast Cancer Growth. Advanced Healthcare Materials. 13(29). e2401373–e2401373. 6 indexed citations
3.
Luo, Yuting, Xueru Song, Zhe Yang, et al.. (2024). Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO Molecular Medicine. 16(2). 251–266. 15 indexed citations
4.
Wang, Xinyue, Xiang Li, Lin Li, et al.. (2023). Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (Adv. Sci. 12/2023). Advanced Science. 10(12). 1 indexed citations
5.
Chun, Wang, Wenting Yu, Xiaowen He, et al.. (2023). Bivalent Gadolinium Ions Forming Injectable Hydrogels for Simultaneous In Situ Vaccination Therapy and Imaging of Soft Tissue Sarcoma. Advanced Healthcare Materials. 12(26). e2300877–e2300877. 14 indexed citations
6.
Ding, Naiqing, Qin Liu, Juan Du, et al.. (2023). Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma. Clinical & Translational Immunology. 12(9). e1467–e1467. 1 indexed citations
7.
8.
Chu, Yanhong, Yaohua Ke, Xiaoyu Feng, et al.. (2022). Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma. Journal of Nanobiotechnology. 20(1). 190–190. 40 indexed citations
9.
10.
Shen, Jie, Ling Yuan, Yang Yan, et al.. (2020). A novel device to capture circulating tumor cells: Quantification and molecular analysis in lung cancer patients. Journal of Biomaterials Applications. 35(1). 49–58. 2 indexed citations
11.
Liu, Fangcen, Lifeng Wang, Chen Xie, et al.. (2020). <p>Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells</p>. International Journal of Nanomedicine. Volume 15. 1283–1295. 27 indexed citations
12.
Yu, Lixia, Anjie Dong, Ruiwei Guo, et al.. (2018). DOX/ICG Coencapsulated Liposome-Coated Thermosensitive Nanogels for NIR-Triggered Simultaneous Drug Release and Photothermal Effect. ACS Biomaterials Science & Engineering. 4(7). 2424–2434. 98 indexed citations
13.
Liu, Shanshan, Ye Tao, Lixia Yu, et al.. (2016). Analysis of Small RNAs in Streptococcus mutans under Acid Stress—A New Insight for Caries Research. International Journal of Molecular Sciences. 17(9). 1529–1529. 20 indexed citations
14.
Wei, Jia, Ying Huang, Nan Wu, Lixia Yu, & B. Liu. (2016). KRAS mutation and protein levels in gastric cancer patients and response to MEK inhibitors. Annals of Oncology. 27. vi214–vi214. 2 indexed citations
15.
Liu, Baorui, Fangbo Cui, Qin Liu, et al.. (2014). Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells. International Journal of Nanomedicine. 9. 2345–2345. 31 indexed citations
16.
Qian, Xiaoping, Bo Yan, Xuefei Zhou, et al.. (2013). Synergistic Antiangiogenic Activity of Tetrandrine Combined with Endostar on the Human Umbilical Vein Endothelial Cell Model. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 385–390. 9 indexed citations
17.
Qian, Xiaoping, Lijing Zhu, Jing Hu, et al.. (2012). Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model. Journal of Ethnopharmacology. 143(1). 256–261. 8 indexed citations
18.
Zou, Zhengyun, Jia Wei, Xiaolin Li, et al.. (2012). Enhancement of Anticancer Efficacy of Chemotherapeutics by Gambogic Acid Against Gastric Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 27(5). 299–306. 16 indexed citations
19.
Luo, Ningning, et al.. (2010). Real-time mask-division technique based on DMD digital lithography. Optica Applicata. 40. 1 indexed citations
20.
Liu, Baorui, et al.. (2008). Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids. Cancer Letters. 268(1). 166–175. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoping Qian Breakdown of academic impact, for papers by Ling Ding Breakdown of academic impact, for papers by Aiping Tong Breakdown of academic impact, for papers by Lingli Chen Breakdown of academic impact, for papers by Anupama Munshi Breakdown of academic impact, for papers by Khaled Seidi Breakdown of academic impact, for papers by Xiaodong Xie Breakdown of academic impact, for papers by Jia Wei Breakdown of academic impact, for papers by Mohammad Hojjat‐Farsangi
Rankless by CCL
2026